Department of Nephrology, Gülhane School of Medicine, 06018 Etlik, Ankara, Turkey.
Clin J Am Soc Nephrol. 2010 Jan;5(1):45-50. doi: 10.2215/CJN.05080709. Epub 2009 Oct 15.
Hemoglobin (Hb) is the main carrier and buffer of nitric oxide. Evidence has been produced that Hb concentration is inversely related with endothelial function in human diseases. Testing whether this association exists also in diabetic patients stage 1 to 2 chronic kidney disease (CKD) is important because anemia in these patients starts at an earlier stage than in other renal diseases. The relationship was investigated between Hb and flow-mediated dilation (FMD) levels of the patients with diabetic nephropathy in a cross-sectional design.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Eighty-nine diabetics with mild to moderate proteinuria and normal to mildly reduced GFR who were normotensive, nondyslipidemic, and cardiovascular-events free were enrolled. None of the patients was taking metformin or renin-angiotensin system blockers.
FMD was inversely related with Hb levels. Furthermore, there was an inverse link between proteinuria and FMD. However, further analysis of this association showed that the FMD-proteinuria link was confined to patients with proteinuria exceeding 150 mg/d, while no such association existed in patients with proteinuria <150 mg/d. Adjustment of the Hb-FMD relationship for pertinent Framingham risk factors, proteinuria, homeostasis model assessment (HOMA) index, and GFR levels had a modest influence on this association, which remained significant.
Endothelial function is inversely associated with Hb levels in diabetic patients with stage 1 to 2 CKD, and proteinuria is an effect modifier of this association. Overall, the observations of this study generate the hypothesis that proteinuria exposes a situation wherein Hb may limit the endothelium-mediated vasoregulation in diabetes.
血红蛋白(Hb)是一氧化氮的主要载体和缓冲剂。有证据表明,Hb 浓度与人类疾病中的内皮功能呈负相关。检测这种关联是否也存在于 1 至 2 期慢性肾脏病(CKD)的糖尿病患者中非常重要,因为这些患者的贫血发生在其他肾脏疾病之前。本研究采用横断面设计,检测 Hb 与糖尿病肾病患者血流介导的舒张(FMD)水平之间的关系。
设计、地点、参与者和测量方法:共纳入 89 例轻中度蛋白尿和正常至轻度降低肾小球滤过率的非高血压、非血脂异常和无心血管事件的糖尿病患者。所有患者均未服用二甲双胍或肾素-血管紧张素系统阻滞剂。
FMD 与 Hb 水平呈负相关。此外,蛋白尿与 FMD 之间存在负相关。然而,进一步分析表明,FMD 与蛋白尿之间的联系仅限于蛋白尿超过 150mg/d 的患者,而蛋白尿 <150mg/d 的患者则不存在这种关联。调整 Hb-FMD 关系,纳入相关弗雷明汉风险因素、蛋白尿、稳态模型评估(HOMA)指数和肾小球滤过率水平,对这种关联只有适度影响,但仍具有统计学意义。
1 至 2 期 CKD 糖尿病患者的内皮功能与 Hb 水平呈负相关,而蛋白尿是这种关联的效应修饰因子。总的来说,本研究的观察结果提出了一个假设,即蛋白尿使 Hb 可能限制糖尿病患者内皮介导的血管调节的情况。